This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: James R Swartling: Innovator in Recombinant DNA Technology
Introduction
James R Swartling is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. His work has implications for various applications in medicine and research.
Latest Patents
James R Swartling holds a patent for "Recombinant DNA compounds and expression vectors encoding." This invention provides isolated DNA compounds and recombinant DNA cloning and expression vectors that encode PNB esterase from Bacillus subtilis. The invention also includes host cells transformed with these vectors and a method for the production of the PNB esterase by recombinant DNA techniques. He has 1 patent to his name.
Career Highlights
Swartling is associated with Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development in healthcare. His role at the company has allowed him to contribute to advancements in biotechnology and pharmaceuticals.
Collaborations
Throughout his career, James R Swartling has worked alongside notable colleagues, including Cathleen Alice Cantwell and Roland L Hodges. Their collaborative efforts have furthered research and development in their respective fields.
Conclusion
James R Swartling's contributions to recombinant DNA technology exemplify the impact of innovation in biotechnology. His work continues to influence advancements in medical research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile